| Literature DB >> 25390887 |
Hanne Sørup Tastesen1, Alexander Krokedal Rønnevik1, Kamil Borkowski2, Lise Madsen1, Karsten Kristiansen2, Bjørn Liaset3.
Abstract
Low-protein and high-protein diets regulate energy metabolism in animals and humans. To evaluate whether different dietary protein sources modulate energy balance when ingested at average levels obesity-prone male C57BL/6J mice were pair-fed high-fat diets (67 energy percent fat, 18 energy percent sucrose and 15 energy percent protein) with either casein, chicken filet or a mixture of cod and scallop (1:1 on amino acid content) as protein sources. At equal energy intake, casein and cod/scallop fed mice had lower feed efficiency than chicken fed mice, which translated into reduced adipose tissue masses after seven weeks of feeding. Chicken fed mice had elevated hepatic triglyceride relative to casein and cod/scallop fed mice and elevated 4 h fasted plasma cholesterol concentrations compared to low-fat and casein fed mice. In casein fed mice the reduced adiposity was likely related to the observed three percent lower apparent fat digestibility compared to low-fat, chicken and cod/scallop fed mice. After six weeks of feeding an oral glucose tolerance test revealed that despite their lean phenotype, casein fed mice had reduced glucose tolerance compared to low-fat, chicken and cod/scallop fed mice. In a separate set of mice, effects on metabolism were evaluated by indirect calorimetry before onset of diet-induced obesity. Spontaneous locomotor activity decreased in casein and chicken fed mice when shifting from low-fat to high-fat diets, but cod/scallop feeding tended (P = 0.06) to attenuate this decrease. Moreover, at this shift, energy expenditure decreased in all groups, but was decreased to a greater extent in casein fed than in cod/scallop fed mice, indicating that protein sources regulated energy expenditure differently. In conclusion, protein from different sources modulates energy balance in C57BL/6J mice when given at normal levels. Ingestion of a cod/scallop-mixture prevented diet-induced obesity compared to intake of chicken filet and preserved glucose tolerance compared to casein intake.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25390887 PMCID: PMC4229262 DOI: 10.1371/journal.pone.0112859
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Composition of the experimental diets.
| LF | Casein | Chicken | Cod/scallop | |
|
| ||||
| Casein | 190 | 215 | − | − |
| Chicken | − | − | 240 | − |
| Cod | − | − | − | 114 |
| Scallop | − | − | − | 133 |
| L-Cystine | 2.8 | 3 | 3 | 3 |
| KCl | − | 10.2 | 5.4 | − |
| Corn starch | 299 | − | − | − |
| Maltodextrin 10 | 33 | − | − | − |
| Sucrose | 332 | 242 | 223 | 221 |
| Lard | 19 | 198 | 198 | 198 |
| Vegetable oil | 23.7 | 198 | 198 | 198 |
| Cellulose | 47.4 | 50 | 50 | 50 |
| AIN-76 mineral mix | 9.5 | 67 | 67 | 67 |
| AIN-76 vitamin mix | 9.5 | 14 | 14 | 14 |
| Choline bitartrate | 1.9 | 2 | 2 | 2 |
| Butylated hydroxytoluene | − | 0.4 | 0.4 | 0.4 |
| DiCalcium Phosphate | 12.3 | − | − | − |
| Calcium Carbonate | 5.2 | − | − | − |
| Potassium Citrate, 1 H2O | 15.6 | − | − | − |
|
| ||||
| Crude protein | 170 | 190 | 190 | 200 |
| Ash | 31 | 48 | 60 | 75 |
| Fat | 44 | 390 | 400 | 390 |
| Gross energy kJ/g | 17.4 | 26.2 | 26.0 | 25.5 |
OpenSource diet no. D12450B (Research Diets, Inc. NJ, USA).
Casein (cat. no. C8654, lot BCBC 3986, Sigma-Aldrich, MO, USA).
Chicken breast fillets (Kyllingfilet naturell, Ytterøykylling AS, Norway).
Cod fillets (Wildcaught in the Northeastern Atlantic) and Canadian scallops, (Wild North Atlantic scallops, 20–30 ct, Placopecten magellanicus, Clearwater Seafoods Limited, NS, Canada).
LF: soybean oil. Casein, chicken and cod/scallop: corn oil.
Mineral Mix S10026.
Vitamin Mix V100001.
Crude protein, N x 6.15 for casein; N x 5.6 for chicken filet and cod/scallop.
Amino acid composition of the experimental diets.
| LF | Casein | Chicken | Cod/scallop | |
|
| ||||
| Ala | 60 | 68 | 138 | 119 |
| Arg | 31 | 36 | 66 | 73 |
| Asx | 100 | 109 | 154 | 149 |
| Cys | 28 | 36 | 48 | 42 |
| Glx | 274 | 307 | 212 | 191 |
| Gly | 40 | 47 | 109 | 192 |
| His | 29 | 34 | 43 | 21 |
| Ile | 66 | 77 | 75 | 61 |
| Leu | 120 | 142 | 126 | 107 |
| Lys | 99 | 112 | 136 | 116 |
| Met | 29 | 34 | 36 | 34 |
| Phe | 51 | 59 | 48 | 41 |
| Pro | 153 | 185 | 61 | 47 |
| Ser | 94 | 107 | 78 | 73 |
| Thr | 63 | 70 | 78 | 64 |
| Trp | 9 | 11 | 11 | 8 |
| Tyr | 36 | 44 | 28 | 24 |
| Val | 94 | 111 | 88 | 69 |
| Hyp | <0.1 | <0.1 | 3 | 3 |
| Tau | <0.1 | <0.1 | 1 | 61 |
| EAA | 551 | 640 | 630 | 512 |
| BCAA | 280 | 330 | 290 | 237 |
| Total AA | 1376 | 1590 | 1540 | 1494 |
* essential animo acids.
Asx: sum of Asp + Asn.
Glx: sum of Glu + Gln.
EAA: sum of essential amino acids.
BCAA: sum of branched-chain amino acids.
Total AA: total sum of amino acids.
Figure 1Casein and cod/scallop protein reduces body mass gain and adiposity despite equal energy intake.
A: Growth curve during six weeks. B: Body mass gain. C: Cumulative and total energy intake. D: Feed efficiency. E: Adipose tissue masses. F: Apparent fat digestibility. G: Lean tissue masses. H: Apparent nitrogen digestibility. A-H in male C57BL/6J mice fed the experimental diets for six weeks. Data (Expt. 1) represent group means (n = 7–8) ± SEM analyzed by one-way ANOVA followed by Tukey's pair-wise comparisons. Body mass development and cumulative energy intake were analyzed by repeated measurements ANOVA followed by Tukey's post hoc. Means that do not share a letter are significantly different (P<0.05). # indicates significantly higher body mass in LF fed than in casein fed mice. * indicates significantly higher body mass in chicken fed than in casein fed mice. ¤ indicates significantly higher body mass in chicken fed than in cod/scallop fed mice.
4 h fasted plasma metabolites, liver lipids and liver relative gene expression.
| LF | Casein | Chicken | Cod/scallop |
| |
|
| |||||
| Total cholesterol (mmol/L) | 3.24±0.18b | 3.54±0.18b | 4.53±0.19a | 3.88±0.15ab | <0.001 |
| HDL cholesterol (mmol/L) | 2.68±0.13c | 3.14±0.13bc | 3.72±0.17a | 3.23±0.13ab | <0.001 |
| HDL:total cholesterol ratio | 0.83±0.01b | 0.89±0.01a | 0.82±0.01b | 0.83±0.01b | 0.001 |
| LDL cholesterol (mmol/L) | 0.87±0.05c | 0.97±0.08bc | 1.42±0.08a | 1.16±0.07ab | <0.001 |
| Total bile acids (mmol/L) | 3.0±0.29a | 2.7±0.23ab | 1.9±0.17b | 2.4±0.19ab | 0.009 |
| TG (mmol/L) | 0.75±0.07a | 0.40±0.03c | 0.65±0.05ab | 0.50±0.06bc | <0.001 |
| FFA (mmol/L) | 0.46±0.04 | 0.32±0.04 | 0.27±0.03 | 0.33±0.07 | 0.079 |
| Glycerol (mmol/L) | 0.32±0.02a | 0.24±0.02b | 0.26±0.02ab | 0.25±0.02b | 0.025 |
| β-hydroxybutyrate (mmol/L) | 0.42±0.11 | 0.34±0.04 | 0.21±0.08 | 0.25±0.05 | 0.21 |
| Alanine aminotransferase (U/L) | 24±3 | 28±9 | 26±2 | 50±17 | 0.25 |
|
| |||||
| TG (mg/g) | 29±7ab | 26±3b | 49±9a | 25±3b | 0.020 |
| Total neutral lipid (mg/g) | 35±7ab | 30±3b | 53±9a | 29±3b | 0.026 |
| Cholesterol (mg/g) | 2.9±0.09a | 2.4±0.09b | 2.5±0.06ab | 2.7±0.15ab | 0.037 |
| Steryl ester (mg/g) | 3.0±0.44a | 1.6±0.16b | 1.6±0.19b | 1.2±0.10b | <0.001 |
| Diglycerides (mg/g) | 0.2±0.06 | 0.2±0.03 | 0.2±0.03 | 0.1±0.02 | 0.52 |
|
| |||||
|
| 1±0.28 | 0.82±0.27 | 1.22±0.25 | 1.52±0.34 | 0.36 |
|
| 1±0.26 | 0.94±0.13 | 1.11±0.12 | 1.04±0.13 | 0.90 |
|
| 1±0.39 | 0.81±0.14 | 0.76±0.10 | 0.89±0.15 | 0.88 |
|
| 1±0.25a | 0.06±0.01b | 0.03±0.01b | 0.02±0.00b | <0.001 |
|
| 1±0.06 | 0.70±0.06 | 0.98±0.13 | 0.73±0.09 | 0.054 |
|
| 1±0.15b | 1.87±0.44ab | 1.95±0.34ab | 2.64±0.49a | 0.044 |
|
| 1±0.12a | 0.32±0.05b | 0.53±0.12ab | 0.95±0.21a | 0.006 |
|
| 1±0.26a | 0.43±0.12b | 0.51±0.10b | 0.48±0.04b | 0.043 |
|
| 1±0.19 | 0.81±0.06 | 1.21±0.25 | 0.91±0.11 | 0.42 |
|
| 1 ±0.13a | 0.41±0.06b | 0.85±0.15ab | 0.75±0.10ab | 0.014 |
|
| 1 ±0.25a | 0.55±0.08ab | 0.71±0.13ab | 0.41±0.05b | 0.042 |
Data represent group means (n = 6–8) ± SEM analyzed by one-way ANOVA followed by Tukey's post hoc. Means that do not share a superscript letter are significantly different (P<0.05). Abbreviations: TG, triglycerides; FFA, free fatty acids; Srebf1, sterol regulatory element-binding transcription factor 1; Acaca, acetyl-coenzyme A carboxylase alpha; Fasn, fatty acid synthase; Scd-1, stearoyl-CoA desaturase-1; Dgat-1, diacylglycerol acyltransferase-1; Hmgcr, 3-hydroxy-3-methylglutaryl-coenzyme A reductase; Pck-1, phosphoenol pyruvate carboxykinase-1; Hk2, hexokinase 2; Hk4, hexokinase 4; Pfkl, phosphofructokinase, liver, B-type; Pklr, pyruvate kinase liver and red blood cell.
Figure 2Casein tends to reduce glucose tolerance while chicken tends to cause increased plasma insulin concentration.
A: Blood glucose measured before and at 15, 30, 60 and 120 minutes after oral administration of glucose (gavage, 2 mg/g body mass) during 6 h fasted oral glucose tolerance test in mice after six weeks on the experimental diets (O-GTT). B: 6 h fasted blood glucose. C: glucose dose administered by oral gavage. D: incremental blood glucose area under the curve (iAUC). E: Plasma lactate. F: Plasma glucose. G: Plasma insulin. E-G: concentrations measured in 4 h fasted plasma collected at the termination of the mice after seven weeks on the experimental diets. H: Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) scores. I: Quantitative Insulin Sensitivity Check Index (QUICKI) scores. H-I: The scores were calculated based on 4 h fasted plasma glucose and insulin levels. Data (Expt. 1) represent group means (n = 7–8) ± SEM analyzed by one-way ANOVA followed by Tukey's pair-wise comparisons. O-GTT curve was analyzed by repeated measurements ANOVA followed by Tukey's post hoc. Means that do not share a letter are significantly different (P<0.05). # indicates significantly higher blood glucose in casein fed than in LF fed mice. * indicates significantly higher blood glucose in casein fed than in cod/scallop fed mice. ¤ indicates significantly higher blood glucose in chicken fed than in LF fed mice.
Figure 3Protein sources affect energy expenditure and tend to affect spontaneous locomotor activity.
A: RER in mice fed LF diet for 72 h and HF diets for 72 h in open-circuit indirect calorimetry cages. B: Average respiratory exchange ratio (RER) during 48 h on LF diet and HF diets in light and dark phases. C: Spontaneous locomotor activity during 72 h on LF diet and 72 h on HF diets. D: Spontaneous locomotor activity in light and dark phases during 48 h in mice fed LF diet and HF diets. E: Total spontaneous locomotor activity during 48 h in mice fed LF diet and HF diets. F: Energy expenditure (EE) during 72 h on LF diet and 72 h on HF diets. G: Average EE during 48 h in light and dark phases in mice fed LF diet and HF diets. Data (Expt. 2) represent group means (n = 9–10) ± SEM analyzed by ANOVA followed by Tukey's pair-wise comparisons. RER, activity and EE data were analyzed by repeated measurements ANOVA followed by Tukey's post hoc. Means that do not share a letter are significantly different (P<0.05).